Sangui Biotech International Inc (SGBI) financial statements (2021 and earlier)

Company profile

Business Address 352 SOUTH 200 WEST
FARMINGTON, UT 84025
State of Incorp. CO
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments15272157701898
Cash and cash equivalents15272157701898
Receivables1535 1281768
Prepaid expense1792134  
Other undisclosed current assets676021283895
Total current assets:53791029411072261
Noncurrent Assets
Property, plant and equipment3      
Deferred costs     50 
Total noncurrent assets:3    50 
TOTAL ASSETS:567910294110122261
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:     143 
Other undisclosed accounts payable and accrued liabilities     143 
Debt538478     
Due to related parties3528     
Other undisclosed current liabilities128164453354 319253
Total current liabilities:702671453354 462253
Noncurrent Liabilities
Other undisclosed noncurrent liabilities      517
Total noncurrent liabilities:      517
Total liabilities:702671453354 462770
Stockholders' equity
Stockholders' equity attributable to parent, including:(2)49(351)(261)(248)(340)7
Common stock33,01232,96732,86432,71032,39331,93331,561
Treasury stock, value(19)(19)191919339 
Additional paid in capital4,5134,5134,5134,5134,5134,6214,621
Accumulated other comprehensive income929193 123170 
Accumulated deficit(37,600)(37,504)(37,180)(36,978)(36,669)(36,161)(35,456)
Other undisclosed stockholders' equity attributable to parent  (661)(525)(626)(1,242)(719)
Stockholders' equity attributable to noncontrolling interest(644)(641)     
Other undisclosed stockholders' equity      (517)
Total stockholders' equity:(646)(592)(351)(261)(248)(340)(510)
Other undisclosed liabilities and equity    358  
TOTAL LIABILITIES AND EQUITY:567910294110122261

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Revenues4588776848127133
Cost of revenue
(Cost of Goods and Services Sold)
  (0)(1)(0)(1)(1)
Other undisclosed gross profit0      
Gross profit:4588776748127133
Operating expenses(321)(426)(285)(384)(409)(879)(1,450)
Other operating expense, net    (85) (254)
Operating loss:(276)(338)(208)(317)(446)(752)(1,572)
Nonoperating income (expense)(7)(5) 3(28)(6)0
Investment income, nonoperating    (28) 0
Foreign currency transaction gain, before tax77 3   
Other nonoperating expense     (6) 
Interest and debt expense(25)(12)897069
Other undisclosed loss from continuing operations before equity method investments, income taxes(5)      
Loss from continuing operations before equity method investments, income taxes:(313)(354)(200)(304)(405)(752)(1,563)
Other undisclosed loss from continuing operations before income taxes  (16)(25)(42)(6)(9)
Loss from continuing operations before income taxes:(313)(354)(216)(330)(446)(758)(1,572)
Income tax expense(1)      
Other undisclosed income from continuing operations3      
Loss before gain (loss) on sale of properties:(311)(354)(216)(330)(446)(758)(1,572)
Other undisclosed net income2212     
Net loss:(289)(343)(216)(330)(446)(758)(1,572)
Net income attributable to noncontrolling interest     54 
Other undisclosed net income (loss) attributable to parent2519(29)    
Net loss attributable to parent:(264)(324)(245)(330)(446)(705)(1,572)
Other undisclosed net income (loss) available to common stockholders, basic(10)   24 143
Net loss available to common stockholders, diluted:(274)(324)(245)(330)(422)(705)(1,429)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net loss:(289)(343)(216)(330)(446)(758)(1,572)
Other comprehensive income (loss)98344   (719) 
Other undisclosed comprehensive income344      
Comprehensive income (loss):1531(216)(330)(446)(1,477)(1,572)
Comprehensive income, net of tax, attributable to noncontrolling interest     54 
Other undisclosed comprehensive loss, net of tax, attributable to parent    (47)  
Comprehensive income (loss), net of tax, attributable to parent:1531(216)(330)(493)(1,424)(1,572)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: